Journal profile · Pharmacology & Pharmacy
Revista Espanola de Quimioterapia
ISSN 0214-3429 · eISSN 1988-9518 · Sociedad Espanola de Quiminoterapia · SPAIN · Quarterly · Founded 1988
Revista Espanola de Quimioterapia: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7; diamond open access (no APC); no APC; review over 12 weeks (community reports); community-reported acceptance: easy; 81 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Revista Espanola de Quimioterapia is published by Sociedad Espanola de Quiminoterapia and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing and Antibiotic Use and Resistance, together about 22.6% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
REQ publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine. The Journal particularly welcomes manuscripts on: the practice of evidence-based medicine relating to antimicrobials (clinical trials, systematic reviews and meta-analyses); antimicrobial treatment (pharmacokinetics, pharmacodynamics and prescribing practices); the action of antimicrobial agents and the mechanisms, genetics and epidemiology of antimicrobial resistance; antimicrobial stewardship, and the genetic basis of antimicrobial resistance. Case reports related to infectious diseases current research related to the laboratory diagnosis of human and the role of the laboratory in both the management of infectious diseases and the elucidation of the epidemiology of infections also are welcome Top
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief José BarberánPublisher website
Editorial board by country: none in mainland China; most named Spain 18 (18 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology7.8%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology7.5%
- Antibiotic Use and ResistanceImmunology and Microbiology7.2%
- Nosocomial Infections in ICUMedicine6.7%
- COVID-19 Clinical Research StudiesMedicine6.7%
- SARS-CoV-2 and COVID-19 ResearchMedicine6%
- Pneumonia and Respiratory InfectionsMedicine5.5%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.7LetPub ·
- CiteScore 2026-06
- 4.5LetPub ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 23LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 117OpenAlex ·
- 2-year mean citedness
- 1.45OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 99.41%LetPub ·
Volume
- Articles per year
- 55LetPub ·
Articles by year OpenAlex count · 736 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 4 |
| 2025 | 81 | 81 | 57 |
| 2024 | 82 | 82 | 248 |
| 2023 | 127 | 127 | 588 |
| 2022 | 155 | 155 | 1,231 |
| 2021 | 144 | 144 | 1,154 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 4 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Open access, Peer review
- Authorship * AUTHORSHIP
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. All contributors who do not meet the criteria for authorship should be lis…
Source ↗Publisher website ·- Conflicts of interest * CONFLICTS OF INTEREST
REQ requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a “Conflicts of interest” section before the Reference section the listing all competing interests (financial and non-financial). Where authors have no Conflicts of interest, the statement should read “The author(s) declare(s) that they have no conflicts of interest”. The Edito…
Source ↗Publisher website ·- Publication ethics * MISCONDUCT
We will energetically pursue accusations of misconduct directed at authors, Editors or referees. Accusations should not be made lightly or in the absence of the likelihood of supporting evidence being obtainable. The Journal may take the view that accusations are malicious if supporting evidence cannot be found and may direct sanctions against accusers in such cases. Any accusation of misconduct s…
Source ↗Publisher website ·- Open access * OPEN ACCESS
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose , without asking prior permission from the publisher or the author, except if there is commercial purpose. In this …
Source ↗Publisher website ·- Peer review * PEER REVIEW
This journal operates a single blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor’s dec…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sociedad Espanola de Quiminoterapia
- Country or region
- SPAIN
- Language
- Spanish
- Frequency
- Quarterly
- Founded
- 1988
- ISSN
- 0214-3429
- Electronic ISSN
- 1988-9518
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Revista Espanola de Quimioterapia
What CAS zone is Revista Espanola de Quimioterapia in?
In the 2025 upgraded edition of the CAS Journal Ranking, Revista Espanola de Quimioterapia is in Zone 4 of Medicine, and in Zone 4 of the minor category Microbiology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Revista Espanola de Quimioterapia?
The latest impact factor listed by LetPub is 2.7; CiteScore 4.5, h-index 27.
How long does peer review take at Revista Espanola de Quimioterapia?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Revista Espanola de Quimioterapia based?
Of the 18 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (18). Counted from the institutions listed on the board page; for reference only.
Which databases index Revista Espanola de Quimioterapia?
According to LetPub and DOAJ records, Revista Espanola de Quimioterapia is indexed in SCIE, Scopus and DOAJ.
Is Revista Espanola de Quimioterapia open access, and what is the APC?
Revista Espanola de Quimioterapia is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .